71 filings
ARS
2023 FY
AVTE
Aerovate Therapeutics Inc
26 Apr 24
Annual report to shareholders
5:23pm
DEFA14A
AVTE
Aerovate Therapeutics Inc
26 Apr 24
Additional proxy soliciting materials
7:19am
DEF 14A
AVTE
Aerovate Therapeutics Inc
Definitive proxy
26 Apr 24
7:18am
8-K
AVTE
Aerovate Therapeutics Inc
27 Mar 24
Regulation FD Disclosure
9:22am
10-K
2023 FY
AVTE
Aerovate Therapeutics Inc
Annual report
25 Mar 24
4:15pm
8-K
sg64s
25 Mar 24
Aerovate Therapeutics Announces Full-Year 2023 Financial Results and Business Highlights
4:12pm
S-8
o2yc26ah
8 Jan 24
Registration of securities for employees
5:11pm
8-K
b7s5h c9nwzun3
8 Jan 24
Regulation FD Disclosure
7:59am
8-K
iyg02tt
20 Nov 23
Topline Phase 2b data expected in June 2024
4:46pm
8-K
6k3vxyko 823jyc
13 Nov 23
Aerovate Therapeutics Announces Third Quarter Financial Results and Business Highlights
8:03am
8-K
jc4ndh
14 Aug 23
Aerovate Therapeutics Announces Second Quarter Financial Results and Business Highlights
8:10am
8-K
xmv8 6i4rd2cm07
11 Jul 23
Aerovate Therapeutics Appoints Habib Dable To Its Board of Directors
5:03pm
8-K
5bpcj43gaomd50
21 Jun 23
Other Events
5:14pm
8-K
d32uhh5z03z4 gqbj
8 Jun 23
Submission of Matters to a Vote of Security Holders
4:30pm
8-K
iwhjjsjt6 2hkwxmzn5
15 May 23
Aerovate Therapeutics Announces First Quarter Financial Results and Business Highlights
4:08pm
DEFA14A
900 nd8iouzdap87r
19 Apr 23
Additional proxy soliciting materials
4:31pm